about
sameAs
Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNRThe avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediateThe receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein.Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry.Receptor-triggered membrane association of a model retroviral glycoprotein.A role for glycolipid biosynthesis in severe fever with thrombocytopenia syndrome virus entry.Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptorEfficient infection mediated by viral receptors incorporated into retroviral particles.Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.Characterization of determinants for envelope binding and infection in tva, the subgroup A avian sarcoma and leukosis virus receptorInhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activitiesNa+/H+ exchanger type 1 is a receptor for pathogenic subgroup J avian leukosis virus.Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.The major cellular sterol regulatory pathway is required for Andes virus infectionINSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular GenomesDouble cos site vectors: simplified cosmid cloning.Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entryApplication of gene-editing technologies to HIV-1.Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions.Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion.Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.Ebola virus mediated infectivity is restricted in canine and feline cells.DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.Chinese hamster ovary cell lines selected for resistance to ebolavirus glycoprotein mediated infection are defective for NPC1 expression.Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide.Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein.Identification of murine T-cell epitopes in Ebola virus nucleoprotein.DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.
P50
Q24524815-744ADC40-8B87-4664-9E18-2C764CC5D269Q24541155-FDF5FB8E-89FE-41F1-A72D-7844776A75C2Q30310511-FE6BE794-7E69-4F61-B887-B1A991897859Q30448708-550E4F9B-C44F-4F11-9B61-4C90FEB9F8B7Q30452108-D4DC5D60-1DB7-40A6-BF62-FD6AD646866AQ30452625-24787DF3-BF7F-4BE0-8E24-42589680FA61Q30454419-938C010B-4CD0-4639-8EF7-AA6EE7B06ABEQ33440784-D67C60DE-941D-4AFB-A5FE-FE09255156DEQ33641497-CA5D1734-317F-4D77-88ED-52C450245FDEQ33644217-F51D197B-CE15-49DC-8FDF-CBB254BB5E91Q33782125-CE0E6007-0295-4261-9EA1-2F029FC87750Q33783176-50297DC0-5D13-450E-B822-72EAC5198698Q33783870-42C04490-9489-4AC9-9B25-09F3344BEEDAQ33920306-2D3F3C84-42D8-42D9-8C99-23DE1C64FFF8Q34051627-C6B1B30F-CEE1-47F2-A3B7-3CFB0247D6EFQ34115190-EB82DA08-B9B9-4BD9-8192-B78CE32F3243Q34187711-BE45177A-0251-4D87-828D-1798807BADE0Q34426491-E1CE9A86-453B-42E2-BD10-5275895141A2Q34600362-660E0DFF-5131-42FA-899A-30589A9BD205Q34969474-8015045B-1987-4AFE-B065-2E9A08F831F1Q35091225-DA0499A4-CEE5-4912-9CFD-66886470C800Q36323403-7F0BBA91-B929-499A-9AEC-EC7F9E84E0C8Q36598612-60BE923A-16BE-4C3D-B159-2F88AC443B2AQ37356916-D8985D4F-C7B6-4C19-9AA2-059ECFEDA297Q38328699-D300F4A9-AA98-4A3D-A87D-F6115EB8D504Q38823675-65708BD7-D24C-4FE4-9877-720FE65B85FBQ38874946-B7D31519-8125-4713-8D38-6B89FDCC6BE8Q39571113-DFFC158A-337A-4B7E-9E4F-433988EAD83EQ39872549-A55B522B-B15B-427A-8D4B-77936F391785Q40069548-05B04D30-EAE5-4537-BB88-6A5D2F7FD5F0Q40125232-3507C0D3-016D-4026-B1C3-9B154E0FCC0AQ40213399-B5206E7A-D194-4272-B79D-D139CDEE3C67Q40267837-73D04453-5DB4-4A3F-B561-C3C908E4BE6CQ40274378-6CDCB54A-E2B5-442F-A302-87C58E09B3B9Q40282596-2E9E6269-FB04-45AC-8E85-45260D5AACA2Q40340446-DC774B8D-154D-4DC7-9C5B-372C2A7DCFFAQ40344473-94A36935-63C7-4669-BFF9-4A2D875728C8Q40404708-64E75EEB-BC6C-4580-9E5D-B047F13ACC16Q40540049-6BCF05B7-CF19-414D-84DC-679477996F00Q40568477-454C43AB-FFB7-4B31-AADB-3375C13F72FB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paul Bates
@ast
Paul Bates
@en
Paul Bates
@es
Paul Bates
@nl
Paul Bates
@sl
type
label
Paul Bates
@ast
Paul Bates
@en
Paul Bates
@es
Paul Bates
@nl
Paul Bates
@sl
prefLabel
Paul Bates
@ast
Paul Bates
@en
Paul Bates
@es
Paul Bates
@nl
Paul Bates
@sl
P106
P1153
7201982019
P21
P31
P496
0000-0002-3918-5976